V. Bonnevie‐Nielsen

Author

V. Bonnevie‐Nielsen

Also Known As

Bonnevie-Nielsen V, V BONNEVIE-NIELSEN, V Bonnevie-Nielsen, V. BONNEVIE-NIELSEN, V. BONNEVIE‐NIELSEN, V. Bonnevie-Nielsen, V. Bonnevie‐Nielsen, VAGN BONNEVIE-NIELSEN, Vagn Bonnevie-Nielsen, Vagn Bonnevie‐Nielsen

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital Steno Diabetes Centers University of British Columbia Aarhus University Novo Nordisk (Denmark)

About

V. Bonnevie‐Nielsen is an author at Odense University Hospital specializing in medicine, immunology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	710
2	Health Sciences	5	5	150
3	Biochemistry	3	3	93
4	Natural Sciences	1	1	21
5	Allergy	1	1	27

V. Bonnevie‐Nielsen

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy H.‐H. Parving, U. Smidt, Birgit Friisberg, Diabetologia Glomerular DiseaseUrologyRenal DiseaseRenal FunctionMedicine	1981	220
Variation in Antiviral 2′,5′-Oligoadenylate Synthetase (2′5′AS) Enzyme Activity Is Controlled by a Single-Nucleotide Polymorphism at a Splice-Acceptor Site in the OAS1 Gene V. Bonnevie‐Nielsen, L. Leigh Field, Shao Lu, The American Journal of Human Genetics Antiviral 2′,5′-Oligoadenylate SynthetaseGeneticsViral Polymerase MechanismOligonucleotideMolecular Biology	2005	164
A Major Loss in Islet Mass and B-cell Function Precedes Hyperglycemia in Mice Given Multiple Low Doses of Streptozotocin V. Bonnevie‐Nielsen, Michael W. Steffes, Åke Lernmark Diabetes	1981	117
Cytokines and Bone Loss in a 5-Year Longitudinal Study—Hormone Replacement Therapy Suppresses Serum Soluble Interleukin-6 Receptor and Increases Interleukin-1-Receptor Antagonist: The Danish Osteoporosis Prevention Study Bo Abrahamsen, V. Bonnevie‐Nielsen, E.N. Ebbesen, Journal of Bone and Mineral Research	2000	91
<i>OAS1</i> Splice Site Polymorphism Controlling Antiviral Enzyme Activity Influences Susceptibility to Type 1 Diabetes L. Leigh Field, V. Bonnevie‐Nielsen, Flemming Pociot, Diabetes	2005	79
Increased concentration of the fast‐acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis Maja Jørgensen, V. Bonnevie‐Nielsen British Journal of Haematology	1987	66
The interferon alpha induced protein ISG12 is localized to the nuclear membrane Pia M. Martensen, Max Søgaard, Irene M. Gjermandsen, European Journal of Biochemistry	2001	46
A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin V. Bonnevie‐Nielsen, M. W. Steffes, Åke Lernmark Diabetes Metabolic SyndromeMultiple Low DosesMajor LossMedicinePhysiology	1981	44
Glucagon receptors on isolated hepatocytes and hepatocyte membrane vesicles. Discrete populations with ligand- and environment-dependent affinities. V. Bonnevie‐Nielsen, Howard S. Tager Journal of Biological Chemistry GlycobiologyDeshistidine GlucagonCellular PhysiologyEnvironment-dependent AffinitiesCell Signaling	1983	41
β-Cell Function Relative to Islet Volume and Hormone Content in the Isolated Perfused Mouse Pancreas* V. Bonnevie‐Nielsen, Lene Theil Skovgaard, Åke Lernmark Endocrinology	1983	41

Page 1